Nkarta to participate at upcoming investor conferences

South san francisco, calif., feb. 10, 2022 (globe newswire) -- nkarta, inc. (nasdaq: nktx), a biopharmaceutical company developing engineered natural killer (nk) cell therapies to treat cancer, today announced its participation at these upcoming investor conferences:
NKTX Ratings Summary
NKTX Quant Ranking